These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38877989)
81. Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases. Kojima M; Morita Y; Nakamura N; Shimizu K; Murayama K; Nakamura S Pathol Res Pract; 2008; 204(4):267-72. PubMed ID: 18187262 [TBL] [Abstract][Full Text] [Related]
82. Correlation of the expression of Epstein-Barr virus latent membrane protein and in situ hybridization with biotinylated BamHI-W probes in Hodgkin's disease. Delsol G; Brousset P; Chittal S; Rigal-Huguet F Am J Pathol; 1992 Feb; 140(2):247-53. PubMed ID: 1310829 [TBL] [Abstract][Full Text] [Related]
83. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Herbst H; Dallenbach F; Hummel M; Niedobitek G; Pileri S; Müller-Lantzsch N; Stein H Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4766-70. PubMed ID: 1647016 [TBL] [Abstract][Full Text] [Related]
84. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Pallesen G; Hamilton-Dutoit SJ; Rowe M; Young LS Lancet; 1991 Feb; 337(8737):320-2. PubMed ID: 1671232 [TBL] [Abstract][Full Text] [Related]
86. Human immunodeficiency virus-associated Hodgkin's disease contains latent, not replicative, Epstein-Barr virus. Siebert JD; Ambinder RF; Napoli VM; Quintanilla-Martinez L; Banks PM; Gulley ML Hum Pathol; 1995 Nov; 26(11):1191-5. PubMed ID: 7590691 [TBL] [Abstract][Full Text] [Related]
87. Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1. Okudaira T; Yamamoto K; Kawakami H; Uchihara JN; Tomita M; Masuda M; Matsuda T; Sairenji T; Iha H; Jeang KT; Matsuyama T; Takasu N; Mori N Br J Haematol; 2006 Feb; 132(3):293-302. PubMed ID: 16409294 [TBL] [Abstract][Full Text] [Related]
88. Epstein-Barr Virus Promotes Tumorigenicity and Worsens Hodgkin Lymphoma Prognosis by Activating JAK/STAT and NF-κB Signaling Pathways. Alabiad MA; Said WMM; Saad RHF; Balata R; Mahmoud AA; Metwally EA; Shalaby AM; Samy W; Yehia AM; Yahia AIO; Alorini M; Abdelrahman DI Iran J Med Sci; 2024 Feb; 49(2):88-100. PubMed ID: 38356485 [TBL] [Abstract][Full Text] [Related]
89. The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood. Claviez A; Tiemann M; Peters J; Kreipe H; Schneppenheim R; Parwaresch R Ann Hematol; 1994 Feb; 68(2):61-6. PubMed ID: 8148417 [TBL] [Abstract][Full Text] [Related]
90. Expression of Bcl-2 family members and presence of Epstein-Barr virus in the regulation of cell growth and death in classical Hodgkin's lymphoma. Kim LH; Nadarajah VS; Peh SC; Poppema S Histopathology; 2004 Mar; 44(3):257-67. PubMed ID: 14987230 [TBL] [Abstract][Full Text] [Related]
91. Molecular biology of Hodgkin lymphoma. Küppers R Hematology Am Soc Hematol Educ Program; 2009; ():491-6. PubMed ID: 20008234 [TBL] [Abstract][Full Text] [Related]
92. The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype. Vockerodt M; Morgan SL; Kuo M; Wei W; Chukwuma MB; Arrand JR; Kube D; Gordon J; Young LS; Woodman CB; Murray PG J Pathol; 2008 Sep; 216(1):83-92. PubMed ID: 18566961 [TBL] [Abstract][Full Text] [Related]
93. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site. Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852 [TBL] [Abstract][Full Text] [Related]
94. Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma. Xiao Q; Shen N; Hedvat CV; Moskowitz CH; Sussman LK; Filippa DA; Zelenetz AD; Houldsworth J; Chaganti RS; Teruya-Feldstein J Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):211-5. PubMed ID: 15551733 [TBL] [Abstract][Full Text] [Related]
95. Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma. Gandhi MK; Moll G; Smith C; Dua U; Lambley E; Ramuz O; Gill D; Marlton P; Seymour JF; Khanna R Blood; 2007 Aug; 110(4):1326-9. PubMed ID: 17438085 [TBL] [Abstract][Full Text] [Related]
96. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces. Huang Q; Wilczynski SP; Chang KL; Weiss LM Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197 [TBL] [Abstract][Full Text] [Related]
97. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma? Khan G Exp Hematol; 2006 Apr; 34(4):399-406. PubMed ID: 16569586 [TBL] [Abstract][Full Text] [Related]
98. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes. Nagpal P; Descalzi-Montoya DB; Lodhi N Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852 [TBL] [Abstract][Full Text] [Related]
99. Primary pulmonary Hodgkin's lymphoma with Epstein-Barr and cytomegaly virus infections. A case report and differential diagnosis. Stachura T; Malinowski E Pol J Pathol; 2003; 54(1):79-83. PubMed ID: 12817885 [TBL] [Abstract][Full Text] [Related]
100. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?]. Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]